Renagel (Aphena Pharma Solutions – Tennessee, LLC)


Welcome to the PulseAid listing for the Renagel drug offered from Aphena Pharma Solutions – Tennessee, LLC. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aphena Pharma Solutions – Tennessee, LLC
NON-PROPRIETARY NAME: Renagel
SUBSTANCE NAME: SEVELAMER HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-06-06
END MARKETING DATE: 0000-00-00


Renagel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRenagel from Aphena Pharma Solutions – Tennessee, LLC
LABELER NAME: Aphena Pharma Solutions – Tennessee, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 800(mg/1)
START MARKETING DATE: 2008-06-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67544-656_7bba784e-b2dd-4662-a66d-09246be23c7c
PRODUCT NDC: 67544-656
APPLICATION NUMBER: NDA021179

Other SEVELAMER HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aphena Pharma Solutions – Tennessee, LLCRenagel
Atlantic Biologicals CorpsRenagel
Cardinal HealthRenagel
DOH CENTRAL PHARMACYRenagel
Genzyme CorporationRenagel